Logo image of XLNX

XILINX INC (XLNX) Stock Fundamental Analysis

NASDAQ:XLNX - Nasdaq - Common Stock

194.92  -21.63 (-9.99%)

After market: 193.05 -1.87 (-0.96%)

Fundamental Rating

3

Overall XLNX gets a fundamental rating of 3 out of 10. We evaluated XLNX against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. XLNX may be in some trouble as it scores bad on both profitability and health. XLNX shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year XLNX was profitable.
XLNX Yearly Net Income VS EBIT VS OCF VS FCFXLNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M 1B

1.2 Ratios

Industry RankSector Rank
ROA 14.64%
ROE 25.28%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XLNX Yearly ROA, ROE, ROICXLNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 10 20 30

1.3 Margins

Industry RankSector Rank
OM 26.39%
PM (TTM) 25.26%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XLNX Yearly Profit, Operating, Gross MarginsXLNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for XLNX has been increased compared to 1 year ago.
Compared to 1 year ago, XLNX has a worse debt to assets ratio.
XLNX Yearly Shares OutstandingXLNX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M
XLNX Yearly Total Debt VS Total AssetsXLNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 13.19 indicates that XLNX is not in any danger for bankruptcy at the moment.
XLNX has a Debt/Equity ratio of 0.41. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Altman-Z 13.19
ROIC/WACCN/A
WACCN/A
XLNX Yearly LT Debt VS Equity VS FCFXLNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

XLNX has a Current Ratio of 6.62. This indicates that XLNX is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 6.13 indicates that XLNX has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 6.62
Quick Ratio 6.13
XLNX Yearly Current Assets VS Current LiabilitesXLNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 1B 2B 3B 4B

More info and screens

7

3. Growth

3.1 Past

XLNX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.98%, which is quite impressive.
The Earnings Per Share has been growing slightly by 4.85% on average over the past years.
The Revenue has grown by 20.43% in the past year. This is a very strong growth!
The Revenue has been growing slightly by 7.29% on average over the past years.
EPS 1Y (TTM)45.98%
EPS 3Y-2.2%
EPS 5Y4.85%
EPS Q2Q%86.96%
Revenue 1Y (TTM)20.43%
Revenue growth 3Y8.46%
Revenue growth 5Y7.29%
Sales Q2Q%25.85%

3.2 Future

The Earnings Per Share is expected to grow by 19.30% on average over the next years. This is quite good.
XLNX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.09% yearly.
EPS Next Y57.65%
EPS Next 2Y30.1%
EPS Next 3Y25.35%
EPS Next 5Y19.3%
Revenue Next Year23.37%
Revenue Next 2Y16.28%
Revenue Next 3Y13.42%
Revenue Next 5Y11.09%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
XLNX Yearly Revenue VS EstimatesXLNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B 5B
XLNX Yearly EPS VS EstimatesXLNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 51.16 indicates a quite expensive valuation of XLNX.
XLNX's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.25.
With a Price/Forward Earnings ratio of 44.12, XLNX can be considered very expensive at the moment.
XLNX is valuated expensively when we compare the Price/Forward Earnings ratio to 22.15, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 51.16
Fwd PE 44.12
XLNX Price Earnings VS Forward Price EarningsXLNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 39.69
XLNX Per share dataXLNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
XLNX's earnings are expected to grow with 25.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.89
PEG (5Y)10.56
EPS Next 2Y30.1%
EPS Next 3Y25.35%

More info and screens

4

5. Dividend

5.1 Amount

XLNX has a yearly dividend return of 0.76%, which is pretty low.
With a Dividend Yield of 0.76, XLNX pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 0.76%

5.2 History

The dividend of XLNX has a limited annual growth rate of 2.55%.
XLNX has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)2.55%
Div Incr YearsN/A
Div Non Decr YearsN/A
XLNX Yearly Dividends per shareXLNX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 0.5 1 1.5

5.3 Sustainability

9.87% of the earnings are spent on dividend by XLNX. This is a low number and sustainable payout ratio.
XLNX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP9.87%
EPS Next 2Y30.1%
EPS Next 3Y25.35%
XLNX Yearly Income VS Free CF VS DividendXLNX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M 1B
XLNX Dividend Payout.XLNX Dividend Payout, showing the Payout Ratio.XLNX Dividend Payout.PayoutRetained Earnings

More info and screens

XILINX INC

NASDAQ:XLNX (2/11/2022, 8:00:02 PM)

After market: 193.05 -1.87 (-0.96%)

194.92

-21.63 (-9.99%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A N/A
Earnings (Next)02-08 2022-02-08/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners0.17%
Ins Owner Change0%
Market Cap48.41B
Analysts67.2
Price Target192.41 (-1.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.76%
Yearly Dividend1.51
Dividend Growth(5Y)2.55%
DP9.87%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 51.16
Fwd PE 44.12
P/S 13.17
P/FCF N/A
P/OCF N/A
P/B 13.18
P/tB N/A
EV/EBITDA 39.69
EPS(TTM)3.81
EY1.95%
EPS(NY)4.42
Fwd EY2.27%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS14.8
BVpS14.79
TBVpSN/A
PEG (NY)0.89
PEG (5Y)10.56
Profitability
Industry RankSector Rank
ROA 14.64%
ROE 25.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 26.39%
PM (TTM) 25.26%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.62
Quick Ratio 6.13
Altman-Z 13.19
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.98%
EPS 3Y-2.2%
EPS 5Y4.85%
EPS Q2Q%86.96%
EPS Next Y57.65%
EPS Next 2Y30.1%
EPS Next 3Y25.35%
EPS Next 5Y19.3%
Revenue 1Y (TTM)20.43%
Revenue growth 3Y8.46%
Revenue growth 5Y7.29%
Sales Q2Q%25.85%
Revenue Next Year23.37%
Revenue Next 2Y16.28%
Revenue Next 3Y13.42%
Revenue Next 5Y11.09%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A